Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study

Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment

(2016) Silvia Alboni et al.   BRAIN BEHAVIOR AND IMMUNITY

The Differential Susceptibility Hypothesis

(2016) Jay Belsky   JAMA Pediatrics

PREDICTIVE SOCIOECONOMIC AND CLINICAL PROFILES OF ANTIDEPRESSANT RESPONSE AND REMISSION

(2013) Felipe A. Jain et al.   DEPRESSION AND ANXIETY

Antidepressant Treatment Outcome Depends on the Quality of the Living Environment: A Pre-Clinical Investigation in Mice

(2013) Igor Branchi et al.   PLoS One

Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial

(2012) Nicola Wiles et al.   LANCET

Long-term body weight outcomes of antidepressant–environment interactions

(2010) C Mastronardi et al.   MOLECULAR PSYCHIATRY

The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover

(2010) Igor Branchi   PSYCHONEUROENDOCRINOLOGY

Income and attrition in the treatment of depression: a STAR*D report

(2009) Diane Warden et al.   DEPRESSION AND ANXIETY

When to use the odds ratio or the relative risk?

(2008) Carsten Oliver Schmidt et al.   International Journal of Public Health